5- and 6-azaindole compounds for inhibition of bcr-abl tyrosine kinases
TW202631129APending Publication Date: 2026-08-01ENLIVEN INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114139084
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-10-16
- Filing Date
- 2025-10-09
- Publication Date
- 2026-08-01
Smart Images
Figure 00000000_0000_ABST
Abstract
The present disclosure relates to compounds and compositions for inhibition of Bcr-Abl tyrosine kinases, methods of preparing said compounds and compositions, and their use in the treatment of various cancers, such as chronic myeloid leukemia (CML).
Need to check novelty before this filing date? Find Prior Art